Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Receive green light exposure and/or brain stimulation therapy for migraine relief | stella

Back to Migraine trials

Recruiting

Green Light and Brain Stimulation for Migraine Relief

Plain-English translation of NCT06943625 on ClinicalTrials.gov ↗ · Source last updated January 2026 · Translation generated June 2026 · How we translate trials

Read our Migraine research guide →

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This study is testing whether two non-medication approaches—exposure to green light and a gentle electrical brain stimulation technique called transcranial direct current stimulation (tDCS)—can help reduce how often and how severely migraines occur. You would receive one or both of these treatments alongside your regular migraine medication, and researchers will compare how well they work compared to medication alone.

Migraines are a serious, disabling condition that affect millions of people worldwide, and current medications don't work well enough for everyone. This trial is exploring whether these newer approaches might offer additional relief by working with your brain's natural pain pathways.

Do you qualify?

You likely qualify if…

you have been diagnosed with episodic migraines (fewer than 15 headache days per month) or chronic migraines (15 or more headache days per month)
your migraine pain intensity averages 5 or higher on a 0-10 pain scale during the 4 weeks before you enroll
you are able to commit to participating in the study as scheduled

You likely don't qualify if…

you have a serious mental health condition
you are very sensitive to light (photophobic)
you have a shunt, implant, or metal device in your head or brain
you have a brain tumor or a wound on your skull

What participation looks like

You will be randomly assigned to one of four groups: one receiving brain stimulation, one receiving green light exposure, one receiving both treatments, or one receiving only your regular medication as a comparison. Along with whichever treatment you receive, you'll continue taking your prescribed migraine medications. The study will track your migraine frequency and intensity over time to see if the new treatments help reduce your symptoms.

AI-generated summary from trial data · Jun 7, 2026 · Not medical advice

Trial locations(2 sites)

Pakistan

Pakistan Railway Hospital, Rawalpindi, Punjab Province

Pakistan Railway Hospital, Rawalpindi, Punjab Province

Key details

Sponsor

Riphah International University

Enrollment target

~40 participants

Started

April 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated on clinicaltrials.gov in January 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Sufia Omar, DPT

Riphah International University

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov